Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1677-1683
Published online before print July 3, 2003, doi: 10.1161/01.ATV.0000084810.52464.D5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/9/1677    most recent
01.ATV.0000084810.52464.D5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kälvegren, H.
Right arrow Articles by Bengtsson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kälvegren, H.
Right arrow Articles by Bengtsson, T.
Related Collections
Right arrow Secretion
Right arrow Aggregation
Right arrow Thrombosis risk factors
Right arrow Platelets
Right arrow CV surgery: aortic and vascular disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1677.)
© 2003 American Heart Association, Inc.


Thrombosis

Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation

A Causal Role in Cardiovascular Disease?

Hanna Kälvegren; Meytham Majeed; Torbjörn Bengtsson

From the Division of Medical Microbiology, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

Correspondence to Hanna Kälvegren, Division of Medical Microbiology, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden. E-mail hanjo{at}imk.liu.se

Objective— Evidence linking Chlamydia pneumoniae to atherosclerotic cardiovascular disease is expanding. Platelets are considered to play an essential role in cardiovascular diseases; however, so far platelets have not been associated with an infectious cause of atherosclerosis. This study aims to clarify the interaction between C pneumoniae and platelets and possibly present a novel mechanism in the pathogenesis of atherosclerosis.

Methods and Results— The effects of C pneumoniae on platelet aggregation and secretion were assessed with lumiaggregometry, and the ability of C pneumoniae to bind to platelets and stimulate expression of P-selectin was analyzed with flow cytometry. We found that C pneumoniae, at a chlamydia:platelet ratio of 1:15, adheres to platelets and triggers P-selectin expression after 1 minute and causes an extensive aggregation and ATP secretion after 20 minutes of incubation. Inhibition of glycoprotein IIb/IIIa with Arg-Gly-Asp-Ser or abciximab markedly reduced C pneumoniae-induced platelet aggregation. Exposure of C pneumoniae to polymyxin B, but not elevated temperature, abolished the stimulatory effects on platelet activation, suggesting that chlamydial lipopolysaccharide has an active role. In contrast, other tested bacteria had no or only moderate effects on platelet functions.

Conclusion— Our findings demonstrate a new concept of how C pneumoniae activates platelets and thereby may cause atherosclerosis and thrombotic vascular occlusion.


Key Words: atherosclerosis • bacteria–cell interaction • LPS • thrombosis




This article has been cited by other articles:


Home page
BloodHome page
M. Othman, A. Labelle, I. Mazzetti, H. S. Elbatarny, and D. Lillicrap
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance
Blood, April 1, 2007; 109(7): 2832 - 2839.
[Abstract] [Full Text] [PDF]